MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CRVO — CervoMed Inc. Common Stock
NasdaqCervoMed Inc. Common Stock
$3.02
+0.09(+3.07%)
- O
- 2.96
- H
- 3.07
- L
- 2.88
- V
- 211.29K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CRVO
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJun 18, 1996
Employees15
Stock ExchangeNasdaq
Ticker SymbolCRVO
Websitehttps://www.cervomed.com
Key Financial Statistics
| Market Cap | $38.40M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.13 - $10.00 |
| 52-Week Avg Volume | 1.49M |
| VWAP | $2.98 |
| Transactions | 1,393 |
| Total Recorded Bars | 4,619 days |